Copper gluconate
- Generic Name
- Copper gluconate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C12H22CuO14
- CAS Number
- 527-09-3
- Unique Ingredient Identifier
- RV823G6G67
- Background
Copper gluconate is a copper salt of D-gluconic acid that displays a light blue to bluish-green color. It is prepared by the reaction of gluconic acid solutions with cupric oxide or basic cupric carbonate. According to the good manufacturing or feeding practice by the FDA, copper gluconate is used as a nutrient or dietary supplement and is generally recogniz...
- Associated Conditions
- Trace Element Deficiency
- Associated Therapies
- Nutritional supplementation
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
- Conditions
- Interventions
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT05210374
- Locations
- 🇺🇸
Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Study of Disulfiram and Copper Gluconate in Patients With Treatment-Refractory Multiple Myeloma
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2023-03-13
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 2
- Registration Number
- NCT04521335
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2016-11-15
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Daniel George, MD
- Target Recruit Count
- 9
- Registration Number
- NCT02963051
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Conditions
- Interventions
- First Posted Date
- 2016-03-22
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 35
- Registration Number
- NCT02715609
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver
- First Posted Date
- 2008-08-28
- Last Posted Date
- 2014-10-31
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 21
- Registration Number
- NCT00742911
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.